STOCK TITAN

AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) will announce its first-quarter fiscal year 2022 financial results on September 30, 2021, before market opening. A conference call is scheduled for 8:00 a.m. ET on the same day to discuss these results. Investors can participate by dialing 1-877-407-0784 for domestic calls or +1-201-689-8560 for international calls, using passcode 13723182. The call will also be available via webcast on AngioDynamics' website.

Positive
  • None.
Negative
  • None.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2022 before the market open on Thursday, September 30, 2021. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13723182.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 11:00 a.m. ET on Thursday, September 30, 2021, until 11:59 p.m. ET on Thursday, October 7, 2021. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13723182.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics report its first-quarter results for fiscal year 2022?

AngioDynamics will report its first-quarter results for fiscal year 2022 on September 30, 2021.

What time is the AngioDynamics conference call for fiscal Q1 2022 results?

The conference call for AngioDynamics' fiscal Q1 2022 results is scheduled for 8:00 a.m. ET on September 30, 2021.

How can I listen to the AngioDynamics conference call?

You can listen to the AngioDynamics conference call by dialing 1-877-407-0784 for domestic calls or +1-201-689-8560 for international calls, using the passcode 13723182.

Will the AngioDynamics conference call be available as a webcast?

Yes, the conference call will be available as a webcast on the AngioDynamics website.

AngioDynamics, Inc.

NASDAQ:ANGO

ANGO Rankings

ANGO Latest News

ANGO Stock Data

357.18M
38.36M
5.61%
81.33%
2.79%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
LATHAM